Biomedical Engineering Reference
In-Depth Information
Stanbrough, M., Bubley, G.J., Ross, K., Golub, T.R., Rubin, M.A., Penning, T.M., Febbo, P.G.,
and Balk, S.P. 2006. Increased expression of genes converting adrenal androgens to testoster-
one in androgen-independent prostate cancer. Cancer Res 66:2815-2825.
Stingl, J. and Caldas, C. 2007. Molecular heterogeneity of breast carcinomas and the cancer
stem cell hypothesis. Nat. Rev. Cancer 7:791-799.
Taipale, J. and Beachy, P.A. 2001. The Hedgehog and Wnt signalling pathways in cancer.
Nature 411:349-354.
Tang, D.G., Patrawala, L., Calhoun, T., Bhatia, B., Choy, G., Schneider-Broussard, R., and
Jeter, C. 2007. Prostate cancer stem/progenitor cells: identification, characterization, and
implications. Mol. Carcinog. 46:1-14.
Tavil, B., Cetin, M., and Tuncer, M. 2006. CD34/CD117 positivity in assessment of prognosis
in children with myelodysplastic syndrome. Leuk. Res. 30:222-224.
Terry, S., Yang, X., Chen, M.W., Vacherot, F., and Buttyan, R. 2006. Multifaceted interac-
tion between the androgen and Wnt signaling pathways and the implication for prostate
cancer. J. Cell Biochem. 99:402-410.
Thomson, A.A. and Marker, P.C. 2006. Branching morphogenesis in the prostate gland and
seminal vesicles. Differentiation 74:382-392.
Tomlins, S.A., Mehra, R., Rhodes, D.R., Cao, X., Wang, L., Dhanasekaran, S.M., Kalyana-
Sundaram, S., Wei, J.T., Rubin, M.A., Pienta, K.J., Shah, R.B., and Chinnaiyan, A.M. 2007.
Integrative molecular concept modeling of prostate cancer progression. Nat. Genet. 39:41-51.
Tran, C.P., Lin, C., Yamashiro, J., and Reiter, R.E. 2002. Prostate stem cell antigen is a
marker of late intermediate prostate epithelial cells. Mol. Cancer Res 1:113-121.
Tsujimura, A., Koikawa, Y., Salm, S., Takao, T., Coetzee, S., Moscatelli, D., Shapiro, E.,
Lepor, H., Sun, T.T., and Wilson, E.L. 2002. Proximal location of mouse prostate
epithelial stem cells: a model of prostatic homeostasis. J. Cell Biol. 157:1257-1265.
van Leenders, G.J. and Schalken, J.A. 2001. Stem cell differentiation within the human
prostate epithelium: implications for prostate carcinogenesis. BJU Int. 88 Suppl 2:35-42.
Verhagen, A.P., Ramaekers, F.C., Aalders, T.W., Schaafsma, H.E., Debruyne, F.M., and
Schalken, J.A. 1992. Colocalization of basal and luminal cell-type cytokeratins in human
prostate cancer. Cancer Res 52:6182-6187.
Walsh, P.C., DeWeese, T.L., and Eisenberger, M.A. 2007. Clinical practice. Localized pros-
tate cancer. N. Engl. J. Med. 357:2696-2705.
Wang, J.C. and Dick, J.E. 2005. Cancer stem cells: lessons from leukemia. Trends Cell Biol.
15:494-501.
Wang, X.D., Shou, J., Wong, P., French, D.M., and Gao, W.Q. 2004. Notch1-expressing
cells are indispensable for prostatic branching morphogenesis during development and
re-growth
following
castration
and
androgen
replacement.
J. Biol. Chem.
279:24733-24744.
Wang, X.D., Leow, C.C., Zha, J., Tang, Z., Modrusan, Z., Radtke, F., Aguet, M.,
De Sauvage, F.J., and Gao, W.Q. 2006. Notch signaling is required for normal prostatic
epithelial cell proliferation and differentiation. Dev. Biol. 290:66-80.
Wei, C., Guomin, W., Yujun, L., and Ruizhe, Q. 2007. Cancer stem-like cells in human
prostate carcinoma cells DU145: the seeds of the cell line? Cancer Biol. Ther. 6:763-768.
Weng, A.P. and Aster, J.C. 2004. Multiple niches for Notch in cancer: context is everything.
Curr. Opin. Genet. Dev. 14:48-54.
Whittemore, A.S., Kolonel, L.N., Wu, A.H., John, E.M., Gallagher, R.P., Howe, G.R.,
Burch, J.D., Hankin, J., Dreon, D.M., West, D.W., The C.Z., and Paffenbarger R.S., Jr.
1995. Prostate cancer in relation to diet, physical activity, and body size in blacks, whites,
and Asians in the United States and Canada. J. Natl Cancer Inst. 87: 652-661.
Wicha, M.S., Liu, S., and Dontu, G. 2006. Cancer stem cells: an old idea—a paradigm shift.
Cancer Res. 66:1883-1890.
Wissmann, C., Wild, P.J., Kaiser, S., Roepcke, S., Stoehr, R., Woenckhaus, M., Kristiansen,
G., Hsieh, J.C., Hofstaedter, F., Hartmann, A., Knuechel, R., Rosenthal, A., and
